|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
affects response to substance |
ISO |
ABCA1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
Mitoxantrone results in increased expression of ABCB1 protein |
CTD |
PMID:15239124 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
affects export affects response to substance increases transport multiple interactions increases export increases expression decreases abundance decreases response to substance affects uptake affects transport increases response to substance |
ISO |
ABCG2 protein affects the export of Mitoxantrone ABCG2 protein affects the susceptibility to Mitoxantrone ABCG2 protein results in increased transport of Mitoxantrone 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; [3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] inhibits the reaction [Folic Acid deficiency results in decreased susceptibility to Mitoxantrone]; [3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased export of Mitoxantrone; [5-Methoxypsoralen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Mitoxantrone; [Folic Acid deficiency results in increased expression of ABCG2 protein] which results in decreased susceptibility to Mitoxantrone; [GSK 1363089 results in decreased activity of ABCG2 protein] which results in decreased export of Mitoxantrone; [Methoxsalen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone; [MLN 8237 affects the activity of ABCG2 protein] which affects the export of Mitoxantrone; [Novobiocin results in decreased activity of ABCG2 protein] which results in decreased export of Mitoxantrone; ABCG2 gene mutant form results in increased export of and results in decreased susceptibility to Mitoxantrone; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone]; ABCG2 protein results in increased export of and results in decreased susceptibility to Mitoxantrone; Beclomethasone inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Cadmium Chloride inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Chlorpromazine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; chrysin inhibits the reaction [ABCG2 protein results in increased secretion of Mitoxantrone]; Clozapine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Cyclosporine inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Dactinomycin inhibits the reaction [Mitoxantrone results in increased expression of ABCG2 mRNA]; desisobutyrylciclesonide inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Erlotinib Hydrochloride inhibits the reaction [ABCG2 gene mutant form results in decreased susceptibility to Mitoxantrone]; Erlotinib Hydrochloride inhibits the reaction [ABCG2 protein results in decreased susceptibility to Mitoxantrone]; GSK 1363089 inhibits the reaction [ABCG2 protein results in decreased susceptibility to Mitoxantrone]; Haloperidol inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Lapatinib inhibits the reaction [ABCG2 gene mutant form results in increased export of and results in decreased susceptibility to Mitoxantrone]; Lapatinib inhibits the reaction [ABCG2 protein results in increased export of and results in decreased susceptibility to Mitoxantrone]; Mometasone Furoate inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Novobiocin inhibits the reaction [[5-Methoxypsoralen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone]; Novobiocin inhibits the reaction [[Methoxsalen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone]; Olanzapine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; oxfendazole inhibits the reaction [ABCG2 protein affects the transport of Mitoxantrone]; Paliperidone Palmitate inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Porphyrins inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Protons promotes the reaction [ABCG2 protein results in decreased susceptibility to Mitoxantrone]; Quetiapine Fumarate inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Risperidone inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 gene mutant form results in increased export of and results in decreased susceptibility to Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 protein affects the uptake of Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 protein results in increased export of and results in decreased susceptibility to Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone] Mitoxantrone results in increased expression of ABCG2 mRNA; Mitoxantrone results in increased expression of ABCG2 protein ABCG2 protein results in decreased abundance of Mitoxantrone ABCG2 protein results in increased susceptibility to Mitoxantrone |
CTD |
PMID:10606239 PMID:12869632 PMID:15239124 PMID:15640379 PMID:15695404 PMID:15703302 PMID:15875186 PMID:16442095 PMID:16636798 PMID:16954373 PMID:17032904 PMID:17093006 PMID:18623116 PMID:18829547 PMID:18834354 PMID:19428349 PMID:20019844 PMID:21712253 PMID:22892056 PMID:24994473 PMID:29079042 PMID:34717915 PMID:34896433 PMID:38367674 More...
|
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ACADVL protein |
CTD |
PMID:34246718 |
|
NCBI chr10:55,231,558...55,236,786
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
affects response to substance |
ISO |
ACSL3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ACTA1 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
affects response to substance |
ISO |
ACTG2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
affects response to substance |
ISO |
ADARB1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,583...11,350,852
|
|
G |
Agpat5 |
1-acylglycerol-3-phosphate O-acyltransferase 5 |
affects response to substance |
ISO |
AGPAT5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr16:77,641,887...77,688,148
Ensembl chr16:70,943,135...70,985,560
|
|
G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
affects response to substance |
ISO |
AHCYL1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:195,294,153...195,345,815
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects response to substance |
ISO |
ALDH2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Amotl1 |
angiomotin-like 1 |
affects response to substance |
ISO |
AMOTL1 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 8:19,630,139...19,749,027
Ensembl chr 8:11,353,674...11,467,573
|
|
G |
Ank2 |
ankyrin 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ANK2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
affects response to substance |
ISO |
ASNS protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
affects response to substance |
ISO |
ASS1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atg5 |
autophagy related 5 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATG5 protein |
CTD |
PMID:36216988 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression increases phosphorylation multiple interactions |
ISO EXP |
Mitoxantrone results in decreased expression of ATM mRNA Mitoxantrone results in increased phosphorylation of ATM protein [Poly(ADP-ribose) Polymerase Inhibitors co-treated with Mitoxantrone] results in increased phosphorylation of ATM protein |
CTD |
PMID:22832221 PMID:29913208 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP1A2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP5F1A protein |
CTD |
PMID:34246718 |
|
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP5F1B protein |
CTD |
PMID:34246718 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP5F1C protein |
CTD |
PMID:34246718 |
|
NCBI chr17:73,333,584...73,355,872
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Atp7a |
ATPase copper transporting alpha |
decreases response to substance |
ISO |
ATP7A protein results in decreased susceptibility to Mitoxantrone |
CTD |
PMID:17510416 |
|
NCBI chr X:75,159,635...75,267,094
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Bace2 |
beta-secretase 2 |
affects response to substance |
ISO |
BACE2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:50,176,852...50,258,948
Ensembl chr11:36,707,458...36,789,546
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Mitoxantrone results in increased expression of BAX mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbx |
BBX high mobility group box domain containing |
affects response to substance |
ISO |
BBX protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
affects response to substance |
ISO |
BCAM protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of BCAT1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein; BCL2 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein] Mitoxantrone results in decreased expression of BCL2 mRNA |
CTD |
PMID:8219202 PMID:8840993 PMID:15582267 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein] |
CTD |
PMID:8840993 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Becn1 |
beclin 1 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of BECN1 protein |
CTD |
PMID:36216988 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of BIRC2 protein |
CTD |
PMID:15359644 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
affects expression increases expression |
ISO |
Mitoxantrone affects the expression of BIRC5 mRNA Mitoxantrone results in increased expression of BIRC5 protein |
CTD |
PMID:16638212 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
affects response to substance |
ISO |
BMP7 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
affects response to substance |
ISO |
BST2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Btbd3 |
BTB domain containing 3 |
affects response to substance |
ISO |
BTBD3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CACNA1G mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CACNA2D2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:108,072,454...108,203,173
|
|
G |
Calr |
calreticulin |
affects localization |
ISO |
Mitoxantrone affects the localization of CALR protein |
CTD |
PMID:20003823 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
affects response to substance |
ISO |
CAMK2N1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Casc3 |
CASC3 exon junction complex subunit |
affects response to substance |
ISO |
CASC3 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966
|
|
G |
Casp2 |
caspase 2 |
increases expression increases splicing |
ISO |
Mitoxantrone results in increased expression of CASP2 mRNA alternative form Mitoxantrone results in increased splicing of CASP2 mRNA |
CTD |
PMID:14757846 |
|
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
BCL2 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP3 protein] acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein] |
CTD |
PMID:8840993 PMID:12948851 PMID:16215684 PMID:22700542 PMID:32894303 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases activity |
ISO |
Mitoxantrone results in increased activity of CASP6 protein |
CTD |
PMID:12948851 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
increases activity multiple interactions |
ISO |
Mitoxantrone results in increased activity of CASP7 protein Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP7 protein] |
CTD |
PMID:12948851 PMID:22700542 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Mitoxantrone results in increased activity of CASP8 protein |
CTD |
PMID:12948851 PMID:32894303 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Mitoxantrone results in increased activity of CASP9 protein |
CTD |
PMID:12948851 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity |
EXP |
Mitoxantrone results in decreased activity of CAT protein |
CTD |
PMID:29913208 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin3 |
caveolae associated protein 3 |
affects response to substance |
ISO |
CAVIN3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cavin4 |
caveolae associated protein 4 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CAVIN4 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 5:62,996,906...63,007,677
Ensembl chr 5:62,996,865...63,007,678
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
affects response to substance |
ISO |
CD55 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
affects response to substance |
ISO |
CELF2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Cep15 |
centrosomal protein 15 |
affects response to substance |
ISO |
CEP15 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:12,815,159...12,835,115
Ensembl chr15:12,818,385...12,833,838
|
|
G |
Ces2h |
carboxylesterase 2H |
affects response to substance |
ISO |
CES2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Chrdl1 |
chordin-like 1 |
affects response to substance |
ISO |
CHRDL1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
|
|
G |
Cklf |
chemokine-like factor |
affects response to substance |
ISO |
CKLF protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr19:704,528...712,998
Ensembl chr19:698,033...706,570
|
|
G |
Ckm |
creatine kinase, M-type |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CKM mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Clns1a |
chloride nucleotide-sensitive channel 1A |
affects response to substance |
ISO |
CLNS1A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:161,429,437...161,450,904
Ensembl chr 1:152,019,378...152,039,661
|
|
G |
Clu |
clusterin |
affects response to substance |
ISO |
CLU protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Coch |
cochlin |
affects response to substance |
ISO |
COCH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
affects response to substance |
ISO |
COL11A1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Corin |
corin, serine peptidase |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CORIN mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr14:36,034,613...36,264,671
Ensembl chr14:35,681,304...35,909,503
|
|
G |
Cpvl |
carboxypeptidase, vitellogenic-like |
affects response to substance |
ISO |
CPVL protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:82,981,421...83,091,730
Ensembl chr 4:82,981,422...83,085,655
|
|
G |
Crebl2 |
cAMP responsive element binding protein-like 2 |
affects response to substance |
ISO |
CREBL2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:167,673,359...167,699,299
Ensembl chr 4:167,673,315...167,699,292
|
|
G |
Cs |
citrate synthase |
decreases activity |
ISO |
Mitoxantrone results in decreased activity of CS protein |
CTD |
PMID:34246718 |
|
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
|
|
G |
Csrnp2 |
cysteine and serine rich nuclear protein 2 |
affects response to substance |
ISO |
CSRNP2 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:131,594,232...131,610,075
|
|
G |
Cth |
cystathionine gamma-lyase |
affects response to substance |
ISO |
CTH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
affects response to substance |
ISO |
CXADR protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:30,469,778...30,516,990
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Mitoxantrone results in decreased activity of CYP1A1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Mitoxantrone results in decreased activity of CYP1B1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Dapk1 |
death associated protein kinase 1 |
affects response to substance |
ISO |
DAPK1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
affects response to substance |
ISO |
DDIT4 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
affects response to substance |
ISO |
DHRS2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:32,658,855...32,673,591
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dis3 |
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease |
affects response to substance |
ISO |
DIS3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:82,231,922...82,258,299
Ensembl chr15:75,823,436...75,850,642
|
|
G |
Dmd |
dystrophin |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of DMD mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr X:51,070,098...53,437,845
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
affects response to substance increases expression |
ISO |
DUSP4 protein affects the susceptibility to Mitoxantrone Mitoxantrone results in increased expression of DUSP4 mRNA |
CTD |
PMID:16217747 PMID:26537877 PMID:28940058 |
|
NCBI chr16:64,079,893...64,101,396
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dyrk2 |
dual specificity tyrosine phosphorylation regulated kinase 2 |
affects response to substance |
ISO |
DYRK2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:54,349,610...54,380,106
|
|
G |
Egr1 |
early growth response 1 |
affects response to substance |
ISO |
EGR1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
affects response to substance |
ISO |
EIF2S1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
affects response to substance |
ISO |
EIF5A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Elavl4 |
ELAV like RNA binding protein 4 |
affects response to substance |
ISO |
ELAVL4 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 5:130,285,418...130,429,106
Ensembl chr 5:125,056,848...125,200,446
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
affects response to substance |
ISO |
ELOVL5 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
En2 |
engrailed homeobox 2 |
affects response to substance |
ISO |
EN2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:7,221,096...7,226,943
Ensembl chr 4:7,221,096...7,226,943
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects response to substance |
ISO |
ENC1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
affects response to substance |
ISO |
EPB41L2 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions decreases response to substance |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone]; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Mitoxantrone; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone] |
CTD |
PMID:21712253 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ERBB3 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ETFDH protein |
CTD |
PMID:34246718 |
|
NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
affects response to substance |
ISO |
EVI5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
|
|
G |
Extl2 |
exostosin-like glycosyltransferase 2 |
affects response to substance |
ISO |
EXTL2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:203,922,217...203,946,940
Ensembl chr 2:203,922,187...203,943,653
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
increases expression |
EXP |
Mitoxantrone results in increased expression of FABP3 protein |
CTD |
PMID:22878004 |
|
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fam117a |
family with sequence similarity 117, member A |
affects response to substance |
ISO |
FAM117A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:80,281,411...80,325,345
Ensembl chr10:80,281,408...80,325,343
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions increases expression |
ISO |
Hydrocortisone promotes the reaction [Mitoxantrone results in increased expression of FAS] Mitoxantrone results in increased expression of FAS mRNA; Mitoxantrone results in increased expression of FAS protein |
CTD |
PMID:9676859 PMID:26537877 PMID:28940058 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
decreases response to substance multiple interactions |
ISO |
FASN protein results in decreased susceptibility to Mitoxantrone orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone] |
CTD |
PMID:18281512 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
affects response to substance |
ISO |
FDFT1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of FHL1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
affects response to substance |
ISO |
FLRT3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:127,994,226...128,007,841
|
|
G |
Fndc3a |
fibronectin type III domain containing 3a |
affects response to substance |
ISO |
FNDC3A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:54,099,510...54,276,963
Ensembl chr15:47,689,919...47,866,784
|
|
G |
Foxf2 |
forkhead box F2 |
affects response to substance |
ISO |
FOXF2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,836,777...32,842,176
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
affects response to substance |
ISO |
FYN protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Fzd2 |
frizzled class receptor 2 |
affects response to substance |
ISO |
FZD2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
affects response to substance |
ISO |
GCH1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Mitoxantrone results in increased expression of GDF15 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Glul |
glutamate-ammonia ligase |
affects response to substance |
ISO |
GLUL protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
Mitoxantrone results in increased expression of GPX1 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
affects response to substance |
ISO |
GPX3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
affects response to substance |
ISO |
GUCY1B1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
H2ax |
H2A.X variant histone |
increases expression increases phosphorylation multiple interactions |
ISO EXP |
Mitoxantrone results in increased expression of H2AX protein Mitoxantrone results in increased phosphorylation of H2AX protein Poly(ADP-ribose) Polymerase Inhibitors affects the reaction [Mitoxantrone results in increased expression of H2AX protein] |
CTD |
PMID:19738048 PMID:24994473 PMID:29913208 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of HADHB protein |
CTD |
PMID:34246718 |
|
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hdac4 |
histone deacetylase 4 |
affects response to substance |
ISO |
HDAC4 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hmg20b |
high mobility group 20 B |
affects response to substance |
ISO |
HMG20B protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:8,368,934...8,373,650
Ensembl chr 7:8,368,990...8,373,640
|
|
G |
Hoxa5 |
homeo box A5 |
affects response to substance |
ISO |
HOXA5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:82,632,958...82,636,851
Ensembl chr 4:81,302,353...81,306,234
|
|
G |
Hrc |
histidine rich calcium binding protein |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of HRC mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:95,813,262...95,816,987
Ensembl chr 1:95,813,253...95,816,984
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
affects response to substance |
ISO |
HSPA2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Idh3a |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
affects response to substance decreases expression |
ISO |
IDH3A protein affects the susceptibility to Mitoxantrone Mitoxantrone results in decreased expression of IDH3A protein |
CTD |
PMID:16217747 PMID:34246718 |
|
NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:54,971,740...54,991,084
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
affects response to substance |
ISO |
IFITM1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
affects response to substance |
ISO |
IGF1R protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:15499378 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
affects response to substance |
ISO |
IGF2BP3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:79,391,367...79,525,923
Ensembl chr 4:78,060,494...78,194,865
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
affects response to substance |
ISO |
IGFBP3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
affects response to substance |
ISO |
IGFBP7 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:30,737,164...30,797,314
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
affects response to substance |
ISO |
IL13RA2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr X:115,814,620...115,886,080
Ensembl chr X:111,002,592...111,072,381
|
|
G |
Immt |
inner membrane mitochondrial protein |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of IMMT protein |
CTD |
PMID:34246718 |
|
NCBI chr 4:105,438,657...105,477,370
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
affects response to substance |
ISO |
IQGAP1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:144,088,788...144,178,989
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Irf7 |
interferon regulatory factor 7 |
affects response to substance |
ISO |
IRF7 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irx1 |
iroquois homeobox 1 |
affects response to substance |
ISO |
IRX1 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 1:33,123,122...33,128,951
Ensembl chr 1:31,294,615...31,300,444
|
|
G |
Irx4 |
iroquois homeobox 4 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of IRX4 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:30,030,561...30,039,549
Ensembl chr 1:30,030,561...30,039,549
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
affects response to substance |
ISO |
ISG15 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
affects response to substance |
ISO |
ISG20 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Jak2 |
Janus kinase 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of JAK2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
Tetradecanoylphorbol Acetate promotes the reaction [Mitoxantrone results in increased expression of JUN mRNA] |
CTD |
PMID:8219202 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnab2 |
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
affects response to substance |
ISO |
KCNAB2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:168,182,228...168,270,760
Ensembl chr 5:162,901,896...162,988,243
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of KCNH2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
increases expression |
ISO |
Mitoxantrone results in increased expression of KCNJ2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr10:96,560,225...96,570,788
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of KCNQ1 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:198,291,766...198,624,669
|
|
G |
Krr1 |
KRR1, small subunit processome component homolog |
affects response to substance |
ISO |
KRR1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985
|
|
G |
Lama2 |
laminin subunit alpha 2 |
affects response to substance |
ISO |
LAMA2 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:17,672,536...18,320,530
|
|
G |
Lamb1 |
laminin subunit beta 1 |
affects response to substance |
ISO |
LAMB1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:47,835,525...47,902,585
|
|
G |
Lamc1 |
laminin subunit gamma 1 |
affects response to substance |
ISO |
LAMC1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:67,924,872...68,051,986
Ensembl chr13:65,374,372...65,501,492
|
|
G |
Lbh |
LBH regulator of WNT signaling pathway |
affects response to substance |
ISO |
LBH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:22,568,834...22,593,079
|
|
G |
Ldb3 |
LIM domain binding 3 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of LDB3 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr16:9,855,768...9,920,108
Ensembl chr16:9,855,927...9,918,532
|
|
G |
Lemd2 |
LEM domain nuclear envelope protein 2 |
affects response to substance |
ISO |
LEMD2 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr20:5,282,397...5,296,621
Ensembl chr20:5,282,397...5,296,626
|
|
G |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
affects response to substance |
ISO |
LGR4 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:116,901,968...117,004,584
Ensembl chr 3:96,447,858...96,548,899
|
|
G |
Lipa |
lipase A, lysosomal acid type |
affects response to substance |
ISO |
LIPA protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:232,024,356...232,057,633
|
|
G |
Lipg |
lipase G, endothelial type |
affects response to substance |
ISO |
LIPG protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of LMCD1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Lmnb1 |
lamin B1 |
multiple interactions |
ISO |
[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of LMNB1 protein |
CTD |
PMID:15582267 |
|
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Macrod1 |
mono-ADP ribosylhydrolase 1 |
affects response to substance |
ISO |
MACROD1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:204,246,166...204,389,716
|
|
G |
Maff |
MAF bZIP transcription factor F |
affects response to substance |
ISO |
MAFF mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Maged1 |
MAGE family member D1 |
affects response to substance |
ISO |
MAGED1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr X:63,416,464...63,423,167
Ensembl chr X:59,422,717...59,429,364
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
Mitoxantrone results in decreased expression of and results in increased lipidation of MAP1LC3B protein |
CTD |
PMID:36216988 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of MDH2 protein |
CTD |
PMID:34246718 |
|
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
decreases response to substance |
ISO |
MDM2 promoter SNP results in decreased susceptibility to Mitoxantrone |
CTD |
PMID:17575151 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mest |
mesoderm specific transcript |
affects response to substance |
ISO |
MEST protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:59,354,445...59,364,919
Ensembl chr 4:59,354,447...59,366,145
|
|
G |
Mocos |
molybdenum cofactor sulfurase |
affects response to substance |
ISO |
MOCOS protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr18:16,206,402...16,251,928
Ensembl chr18:15,931,654...15,977,187
|
|
G |
Mpc2 |
mitochondrial pyruvate carrier 2 |
affects response to substance |
ISO |
MPC2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:77,728,176...77,747,664
Ensembl chr13:77,728,250...77,747,664
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
affects response to substance |
ISO |
MTHFD2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mxi1 |
MAX interactor 1, dimerization protein |
affects response to substance |
ISO |
MXI1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression multiple interactions |
ISO |
Mitoxantrone results in decreased expression of MYC mRNA Tetradecanoylphorbol Acetate promotes the reaction [Mitoxantrone results in decreased expression of MYC mRNA] |
CTD |
PMID:8219202 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mycbp2 |
MYC binding protein 2 |
affects response to substance |
ISO |
MYCBP2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:86,352,061...86,590,126
Ensembl chr15:79,937,354...80,175,498
|
|
G |
Myh6 |
myosin heavy chain 6 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of MYH6 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr15:32,388,102...32,413,663
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Myh7 |
myosin heavy chain 7 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of MYH7 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Myom2 |
myomesin 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of MYOM2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr16:74,520,148...74,592,658
Ensembl chr16:74,520,157...74,592,772
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
affects response to substance |
ISO |
NAMPT protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Ndufs5 |
NADH:ubiquinone oxidoreductase subunit S5 |
affects response to substance |
ISO |
NDUFS5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:141,258,828...141,264,552
Ensembl chr 5:135,974,034...135,979,603 Ensembl chr14:135,974,034...135,979,603 Ensembl chr 2:135,974,034...135,979,603
|
|
G |
Nefh |
neurofilament heavy chain |
affects response to substance |
ISO |
NEFH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nid2 |
nidogen 2 |
affects response to substance |
ISO |
NID2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,458,084...4,513,843
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
decreases activity |
ISO |
Mitoxantrone results in decreased activity of NR3C1 protein |
CTD |
PMID:19255438 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
affects response to substance |
ISO |
NR4A2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nrap |
nebulin-related anchoring protein |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of NRAP mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:265,355,324...265,433,229
Ensembl chr 1:255,350,113...255,427,693
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
affects response to substance |
ISO |
NRIP1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:14,895,553...14,981,761
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
affects response to substance |
ISO |
OXCT1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:54,963,964...55,112,303
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
P4ha1 |
prolyl 4-hydroxylase subunit alpha 1 |
affects response to substance |
ISO |
P4HA1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
|
|
G |
Pacrgl |
parkin coregulated like |
affects response to substance |
ISO |
PACRGL mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr14:62,532,019...62,556,977
Ensembl chr14:62,532,030...62,556,993
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of PARP1 protein; BCL2 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein]; BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein] |
CTD |
PMID:8840993 PMID:15582267 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pbx1 |
PBX homeobox 1 |
affects response to substance |
ISO |
PBX1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:82,811,664...83,121,447
Ensembl chr13:80,278,770...80,588,594
|
|
G |
Pde4d |
phosphodiesterase 4D |
affects response to substance |
ISO |
PDE4D protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884
|
|
G |
Pde8a |
phosphodiesterase 8A |
affects response to substance |
ISO |
PDE8A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:144,575,203...144,698,216
Ensembl chr 1:135,166,237...135,288,024
|
|
G |
Pdha1 |
pyruvate dehydrogenase E1 subunit alpha 1 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of PDHA1 protein |
CTD |
PMID:34246718 |
|
NCBI chr X:38,509,158...38,522,986
Ensembl chr X:34,700,409...34,714,311
|
|
G |
Phb2 |
prohibitin 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of PHB2 protein |
CTD |
PMID:34246718 |
|
NCBI chr 4:159,203,948...159,208,561
Ensembl chr 4:157,517,577...157,522,272
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
affects response to substance |
ISO |
PHGDH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Plagl1 |
PLAG1 like zinc finger 1 |
affects response to substance |
ISO |
PLAGL1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
|
|
G |
Plat |
plasminogen activator, tissue type |
affects response to substance |
ISO |
PLAT protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plcb4 |
phospholipase C, beta 4 |
affects response to substance |
ISO |
PLCB4 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:122,953,196...123,322,392
|
|
G |
Plpbp |
pyridoxal phosphate binding protein |
affects response to substance |
ISO |
PLPBP protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr16:65,003,292...65,014,886
Ensembl chr16:65,002,223...65,014,886
|
|
G |
Pml |
PML nuclear body scaffold |
affects mutagenesis |
ISO |
Mitoxantrone affects the mutagenesis of PML gene |
CTD |
PMID:19884644 |
|
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:58,628,837...58,658,971
|
|
G |
Ppp1r2 |
protein phosphatase 1, regulatory (inhibitor) subunit 2 |
affects response to substance |
ISO |
PPP1R2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:82,977,634...82,999,426
Ensembl chr11:69,472,555...69,494,463
|
|
G |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of PPP1R3A mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 4:43,905,648...43,946,236
Ensembl chr 4:42,939,599...42,980,638
|
|
G |
Prdm16 |
PR/SET domain 16 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of PRDM16 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 5:170,162,275...170,486,371
Ensembl chr 5:164,880,587...165,203,601
|
|
G |
Prdx2 |
peroxiredoxin 2 |
affects response to substance |
ISO |
PRDX2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prelid3b |
PRELI domain containing 3B |
affects response to substance |
ISO |
PRELID3B protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:183,681,257...183,689,253
Ensembl chr 3:163,262,985...163,271,181
|
|
G |
Prkx |
protein kinase cAMP-dependent X-linked catalytic subunit |
increases expression |
ISO |
Mitoxantrone results in increased expression of PRKX mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr X:45,701,747...45,745,210
Ensembl chr X:41,823,355...41,866,669
|
|
G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
affects response to substance |
ISO |
PTPRE protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:199,774,195...199,924,646
Ensembl chr 1:190,344,401...190,489,534
|
|
G |
Pygm |
glycogen phosphorylase, muscle associated |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of PYGM mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:213,119,805...213,134,622
Ensembl chr 1:203,690,533...203,705,368
|
|
G |
Rara |
retinoic acid receptor, alpha |
affects mutagenesis |
ISO |
Mitoxantrone affects the mutagenesis of RARA gene |
CTD |
PMID:19884644 |
|
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rarb |
retinoic acid receptor, beta |
increases expression |
ISO |
Mitoxantrone results in increased expression of RARB mRNA alternative form |
CTD |
PMID:17608728 |
|
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
affects response to substance |
ISO |
RASA1 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 2:17,593,136...17,676,707
Ensembl chr 2:15,857,980...15,940,854
|
|
G |
Rbbp8 |
RB binding protein 8, endonuclease |
affects response to substance |
ISO |
RBBP8 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr18:3,198,188...3,263,643
Ensembl chr18:2,921,286...2,988,846
|
|
G |
Rbm17 |
RNA binding motif protein 17 |
multiple interactions decreases response to substance |
ISO |
LY 117018 inhibits the reaction [RBM17 protein results in decreased susceptibility to Mitoxantrone]; Tamoxifen inhibits the reaction [RBM17 protein results in decreased susceptibility to Mitoxantrone] |
CTD |
PMID:16061639 |
|
NCBI chr17:71,846,941...71,863,834
Ensembl chr17:66,937,140...66,954,014
|
|
G |
Rcbtb1 |
RCC1 and BTB domain containing protein 1 |
affects response to substance |
ISO |
RCBTB1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:37,430,453...37,477,920
Ensembl chr15:33,319,586...33,365,302
|
|
G |
Rchy1 |
ring finger and CHY zinc finger domain containing 1 |
affects response to substance |
ISO |
RCHY1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:16,397,533...16,413,286
Ensembl chr14:16,113,224...16,129,167
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
affects response to substance |
ISO |
RGS2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Rnd1 |
Rho family GTPase 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of RND1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:129,821,311...129,828,399
|
|
G |
Rragd |
Ras-related GTP binding D |
affects response to substance |
ISO |
RRAGD mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
affects response to substance |
ISO |
RUNX3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:152,644,270...152,702,835
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Ryr2 |
ryanodine receptor 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of RYR2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:58,389,925...58,975,142
|
|
G |
Sall2 |
spalt-like transcription factor 2 |
affects response to substance |
ISO |
SALL2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:27,494,831...27,512,402
Ensembl chr15:25,021,345...25,038,918
|
|
G |
Satb2 |
SATB homeobox 2 |
affects response to substance |
ISO |
SATB2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
|
|
G |
Scd |
stearoyl-CoA desaturase |
affects response to substance |
ISO |
SCD protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Schip1 |
schwannomin interacting protein 1 |
affects response to substance |
ISO |
SCHIP1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:152,127,171...152,888,587
Ensembl chr 2:152,126,953...152,888,585
|
|
G |
Scn2b |
sodium voltage-gated channel beta subunit 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of SCN2B mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 8:54,322,383...54,334,519
Ensembl chr 8:45,425,629...45,437,765
|
|
G |
Scn5a |
sodium voltage-gated channel alpha subunit 5 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of SCN5A mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:119,220,905...119,318,769
|
|
G |
Sdc2 |
syndecan 2 |
affects response to substance |
ISO |
SDC2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Sec31a |
SEC31 homolog A, COPII coat complex component |
affects response to substance |
ISO |
SEC31A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of SERPINE1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sfn |
stratifin |
affects response to substance |
ISO |
SFN protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sfrp4 |
secreted frizzled-related protein 4 |
affects response to substance |
ISO |
SFRP4 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr17:49,974,532...50,026,448
Ensembl chr17:45,234,097...45,330,736
|
|
G |
Slc16a6 |
solute carrier family 16, member 6 |
affects response to substance |
ISO |
SLC16A6 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:94,923,888...94,946,990
Ensembl chr10:94,426,244...94,448,779
|
|
G |
Slc25a11 |
solute carrier family 25 member 11 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of SLC25A11 protein |
CTD |
PMID:34246718 |
|
NCBI chr10:55,856,209...55,859,060
Ensembl chr10:55,357,597...55,360,410
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
affects response to substance |
ISO |
SLC7A5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slco4a1 |
solute carrier organic anion transporter family, member 4a1 |
affects response to substance |
ISO |
SLCO4A1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:187,936,735...187,955,873
Ensembl chr 3:167,559,316...167,578,305
|
|
G |
Smad2 |
SMAD family member 2 |
affects response to substance |
ISO |
SMAD2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
affects response to substance |
ISO |
SORBS1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:249,057,324...249,279,703
Ensembl chr 1:239,108,777...239,330,169
|
|
G |
Spon1 |
spondin 1 |
affects response to substance |
ISO |
SPON1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:177,363,526...177,662,689
Ensembl chr 1:167,928,972...168,228,226
|
|
G |
Spon2 |
spondin 2 |
affects response to substance |
ISO |
SPON2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:81,713,070...81,742,510
Ensembl chr14:77,511,901...77,517,996
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of SPP1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
affects expression decreases expression |
ISO |
Mitoxantrone affects the expression of SQSTM1 protein Mitoxantrone metabolite results in decreased expression of SQSTM1 protein |
CTD |
PMID:36216988 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
affects response to substance |
ISO |
SRD5A1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Sucla2 |
succinate-CoA ligase ADP-forming subunit beta |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of SUCLA2 protein |
CTD |
PMID:34246718 |
|
NCBI chr15:55,161,894...55,215,031
Ensembl chr15:48,752,312...48,805,138
|
|
G |
Sytl2 |
synaptotagmin-like 2 |
affects response to substance |
ISO |
SYTL2 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 1:153,685,403...153,791,758
Ensembl chr 1:144,273,360...144,379,222
|
|
G |
Tagln |
transgelin |
affects response to substance |
ISO |
TAGLN protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
affects response to substance |
ISO |
TAP1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:17523305 |
|
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,656,263...4,666,901
|
|
G |
Tbc1d8 |
TBC1 domain family, member 8 |
affects response to substance |
ISO |
TBC1D8 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 9:41,651,394...41,761,432
Ensembl chr 9:41,651,395...41,761,409
|
|
G |
Tff3 |
trefoil factor 3 |
affects response to substance |
ISO |
TFF3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:9,194,623...9,199,333
Ensembl chr20:9,193,262...9,198,054
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression |
EXP |
Mitoxantrone results in increased expression of TGFB2 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tia1 |
TIA1 cytotoxic granule-associated RNA binding protein |
affects response to substance |
ISO |
TIA1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of TIMP1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tmem47 |
transmembrane protein 47 |
affects response to substance |
ISO |
TMEM47 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr X:49,338,532...49,365,026
Ensembl chr X:45,421,405...45,447,900
|
|
G |
Tnks |
tankyrase |
affects response to substance |
ISO |
TNKS protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr16:57,223,174...57,370,740
Ensembl chr16:57,225,094...57,366,260
|
|
G |
Tnnt1 |
troponin T1, slow skeletal type |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of TNNT1 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:78,349,035...78,359,394
Ensembl chr 1:69,306,362...69,316,721
|
|
G |
Tp53 |
tumor protein p53 |
affects activity |
ISO |
Mitoxantrone affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpd52 |
tumor protein D52 |
affects response to substance |
ISO |
TPD52 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:94,642,514...94,723,442
Ensembl chr 2:92,735,620...92,816,622
|
|
G |
Tpm1 |
tropomyosin 1 |
affects response to substance |
ISO |
TPM1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Trib1 |
tribbles pseudokinase 1 |
affects response to substance |
ISO |
TRIB1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:91,206,579...91,214,731
|
|
G |
Trim2 |
tripartite motif-containing 2 |
affects response to substance |
ISO |
TRIM2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:171,798,654...171,950,193
Ensembl chr 2:169,500,634...169,652,927
|
|
G |
Ubl3 |
ubiquitin-like 3 |
affects response to substance |
ISO |
UBL3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr12:11,509,912...11,554,548
Ensembl chr12:6,473,460...6,518,862
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
affects response to substance |
ISO |
UCHL1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
affects response to substance |
ISO |
UQCRH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:134,782,687...134,790,882
Ensembl chr 5:129,545,984...129,554,242
|
|
G |
Utrn |
utrophin |
affects response to substance |
ISO |
UTRN protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:6,722,594...7,224,313
|
|
G |
Vcan |
versican |
affects response to substance |
ISO |
VCAN protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:20,761,718...20,860,637
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of VDAC1 protein |
CTD |
PMID:34246718 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Wars1 |
tryptophanyl-tRNA synthetase 1 |
affects response to substance |
ISO |
WARS1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:127,776,090...127,807,269
|
|
G |
Washc3 |
WASH complex subunit 3 |
affects response to substance |
ISO |
WASHC3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:22,621,078...22,665,550
Ensembl chr 7:22,621,078...22,690,696
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
affects localization decreases expression |
ISO |
Mitoxantrone affects the localization of XIAP protein Mitoxantrone results in decreased expression of XIAP protein |
CTD |
PMID:15359644 |
|
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
increases expression |
ISO |
Mitoxantrone results in increased expression of YWHAE protein |
CTD |
PMID:32894303 |
|
NCBI chr10:61,082,934...61,120,618
Ensembl chr10:60,584,652...60,671,589
|
|
G |
Zfand1 |
zinc finger AN1-type containing 1 |
affects response to substance |
ISO |
ZFAND1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:93,351,918...93,364,959
Ensembl chr 2:91,444,508...91,453,246
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
increases expression |
ISO |
Mitoxantrone results in increased expression of ZMAT3 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:115,106,966...115,136,863
|
|
G |
Zscan18 |
zinc finger and SCAN domain containing 18 |
affects response to substance |
ISO |
ZSCAN18 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:73,332,883...73,349,846
Ensembl chr 1:73,332,889...73,345,897
|
|